CHINA PIPE (00380) announced its interim results, with a profit attributable to shareholders of HKD 28.35 million, a decrease of 12.69% compared to the same period last year.

17:48 27/08/2026

China Pipe Industry (00380) announced its interim results for the six months ended June 30, 2026, reporting revenue of HKD 334 million, an increase of 1.95% year-on-year; the profit attributable to equity holders of the company for the period was HKD 28.35 million, a decrease of 12.69% year-on-year; earnings per share were HKD 0.0213.

CHINA PIPE (00380) announced its interim results for the six months ended June 30, 2026, reporting revenue of HK$334 million, a year-on-year increase of 1.95%; profit attributable to the equity holders of the company was HK$28.35 million, a year-on-year decrease of 12.69%; earnings per share were HK$0.0213. The announcement stated that the increase in revenue was primarily due to contributions from several public housing projects.

PARADISE ENT (01180) announced its interim results, reporting a loss attributable to shareholders of HKD 71.51 million, a shift from profit to loss compared to the same period last year.

On August 27, SIHUAN PHARM (00460) spent HK$8.111 million to repurchase 10 million shares.

FOSUN INTL (00656): Total revenue for the first half of 2026 reached 86.96 billion yuan, with net profit attributable to the parent company increasing by 160.3% year-on-year.

PARADISE ENT (01180) announced its interim results, reporting a loss attributable to shareholders of HKD 71.51 million, a shift from profit to loss compared to the same period last year.

On August 27, SIHUAN PHARM (00460) spent HK$8.111 million to repurchase 10 million shares.

FOSUN INTL (00656): Total revenue for the first half of 2026 reached 86.96 billion yuan, with net profit attributable to the parent company increasing by 160.3% year-on-year.